Login to Your Account



Push By AstraZeneca Includes COPD Deal Worth Up To $500M

By Nuala Moran


Wednesday, February 7, 2007
LONDON - AstraZeneca plc went through a hyperactive round last week of licensing and acquisitions, sealing deals worth $650 million. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription